Tysabri

Syndicate content

MS Patients May Soon Benefit from a New Generation of Oral Drugs

Greystone Associates Assesses the Potential and Prospects for Pipeline Candidates Targeting Multiple Sclerosis and their Probable Impact on Existing
Treatments

Get the full story...

Despite Risks, Powerful Drugs Offer Hope and Relief to Autoimmune Patients

New Survey by Applied Data Research Analyzes Therapeutic and Commercial Factors in Treating Autoimmune Diseases

Get the full story...

Developers Finding Success of Injectable Drugs Dependent on Numerous Factors

Greystone Associates Analyzes Trends and Prospects for Six Key Drug Classes

Get the full story...

Emerging Targets and Therapeutic Approaches Driving Activity in Autoimmune Disease Therapeutics

New Analysis by Applied Data Research Examines Clinical Developments and Assesses Market Impact

Get the full story...